[开放获取]    关注儿童猴痘易感性的现状、挑战与应对

doi:10.35541/cjd.20250170

Abstract

Abstract: 【Abstract】 Since the global outbreak in 2022, the mpox epidemic has evolved from an African endemic to a public health emergency of international concern. The 2024 mpox outbreak in the Democratic Republic of the Congo caused by the Clade Ⅰb lineage is yet another wake?up call, with markedly higher prevalence and fatality rates observed among children under 15 years of age, thereby presenting new challenges for the children. Therefore, it is necessary to strengthen prevention and control, block mother?to?child transmission routes, and establish innovative models with active community participation to reduce the risk of mpox transmission. In the future, it is urgent to analyze molecular mechanisms underlying the mother?to?child transmission of the virus, develop targeted antiviral drugs, establish a pediatric critical disease scoring system, and incorporate mpox vaccines into the World Health Organization′s expanded programme on immunization.

Key words: Monkeypox, Child, Signs and symptoms, Therapy, Communicable disease control

Lu Qinghua, Yu Dingle, Ma Xiang, Yin Jun, Ma Lin, Yang Yonghong, . Focusing on the status, challenges and countermeasures of mpox susceptibility in children[J]. Chinese Journal of Dermatology, 2025, 58(10): 910-913.doi:10.35541/cjd.20250170

References ［26］

［1］	Krasemann S, Fodjo J, Mohamed O, et al. Public health priorities for mpox clade Ⅰb in pregnant, breastfeeding, and paediatric populations in DR Congo［J］. Lancet Infect Dis, 2025,25（4）:372⁃374. doi: 10.1016/S1473⁃3099（25）00152⁃5.
［2］	Katoto PD, Muttamba W, Bahizire E, et al. Shifting transmission patterns of human mpox in South Kivu, DR Congo［J］. Lancet Infect Dis, 2024,24（6）:e354⁃e355. doi: 10.1016/S1473⁃3099（24）00287⁃1.
［3］	World Health Organization （WHO）. Multi⁃country monkeypox outbreak: situation update［EB/OL］. （2022⁃06⁃27）［2025⁃07⁃20］. https://www.who.int/emergencies/disease⁃outbreak⁃news/item/2022⁃DON396.
［4］	Thornhill JP, Barkati S, Walmsley S, et al. Monkeypox virus infection in humans across 16 countries ⁃ April⁃June 2022［J］. N Engl J Med, 2022,387（8）:679⁃691. doi: 10.1056/NEJMoa2207323.
［5］	Sers R. Humanitarian and health⁃care crises in eastern DR Congo［J］. Lancet, 2025,405（10478）:532⁃533. doi: 10.1016/S0140⁃6736（25）00290⁃9.
［6］	World Health Organization. Mpox⁃Democratic Republic of the Congo［EB/OL］. （2024⁃06⁃14）［2025⁃07⁃20］. https://www.who.int/emergencies/disease⁃outbreak⁃news/item/2024⁃DON522.
［7］	Schwartz DA, Pittman PR. Mpox （monkeypox） in pregnancy: viral clade differences and their associations with varying obstetrical and fetal outcomes［J］. Viruses, 2023,15（8）:1649. doi: 10.3390/v15081649.
［8］	Nachega JB, Mohr EL, Dashraath P, et al. Mpox in pregnancy ⁃ risks, vertical transmission, prevention, and treatment［J］. N Engl J Med, 2024,391（14）:1267⁃1270. doi: 10.1056/NEJMp 2410045.
［9］	Brosius I, Vakaniaki EH, Mukari G, et al. Epidemiological and clinical features of mpox during the clade Ⅰb outbreak in South Kivu, Democratic Republic of the Congo: a prospective cohort study［J］. Lancet, 2025,405（10478）:547⁃559. doi: 10.1016/S0140⁃6736（25）00047⁃9.
［10］	Mitjà O, Alemany A, Marks M, et al. Mpox in people with advanced HIV infection: a global case series［J］. Lancet, 2023,401（10380）:939⁃949. doi: 10.1016/S0140⁃6736（23）00273⁃8.
［11］	Ogoina D, Iroezindu M, James HI, et al. Clinical course and outcome of human monkeypox in Nigeria［J］. Clin Infect Dis, 2020,71（8）:e210⁃e214. doi: 10.1093/cid/ciaa143.
［12］	Huhn GD, Bauer AM, Yorita K, et al. Clinical characteristics of human monkeypox, and risk factors for severe disease［J］. Clin Infect Dis, 2005,41（12）:1742⁃1751. doi: 10.1086/498115.
［13］	Cuérel A, Favre G, Vouga M, et al. Monkeypox and pregnancy: latest updates［J］. Viruses, 2022,14（11）:2520. doi: 10.3390/v14112520.
［14］	Schwartz DA, Mbala⁃Kingebeni P, Patterson K, et al. Congenital mpox syndrome （clade Ⅰ） in stillborn fetus after placental infection and intrauterine transmission, Democratic Republic of the Congo, 2008［J］. Emerg Infect Dis, 2023,29（11）:2198⁃2022. doi: 10.3201/eid2911.230606.
［15］	Deb S, Mondal R, Sen P, et al. Neuroinflammatory disorders of the central nervous system associated with monkeypox virus: a systematic review and call to action［J］. BMC Med, 2025,23（1）:86. doi: 10.1186/s12916⁃025⁃03921⁃6.
［16］	Maru V, Ghaffar UB, Rawat A, et al. Clinical and epidemiological interventions for monkeypox management in children: a systematic review［J］. Cureus, 2023,15（5）:e38521. doi: 10.7759/cureus.38521.
［17］	Rao AK, Schulte J, Chen TH, et al. Monkeypox in a traveler returning from Nigeria ⁃ Dallas, Texas, July 2021［J］. MMWR Morb Mortal Wkly Rep, 2022,71（14）:509⁃516. doi: 10.15585/mmwr.mm7114a1.
［18］	Rizk Y, Lippi G, Henry BM, et al. Update on mpox management: epidemiology, vaccines and therapeutics, and regulatory changes［J］. Drugs, 2025,85（1）:1⁃9. doi: 10.1007/s40265⁃024⁃02117⁃1.
［19］	Nyame J, Punniyakotti S, Khera K, et al. Challenges in the treatment and prevention of monkeypox infection; a comprehensive review［J］. Acta Trop, 2023,245:106960. doi: 10.1016/j.actatropica. 2023.106960.
［20］	Adler H, Gould S, Hine P, et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK［J］. Lancet Infect Dis, 2022,22（8）:1153⁃1162. doi: 10.1016/S1473⁃3099（22）00228⁃6.
［21］	World Health Organization. Clinical management of acute diarrhoea: WHO/UNICEF joint statement［EB/OL］. （2004⁃12⁃08）［2025⁃03⁃25］. https://www.who.int/publications/i/item/WHO_ FCH_CAH_04.7.
［22］	Bhutta ZA, Das JK, Rizvi A, et al. Evidence⁃based interventions for improvement of maternal and child nutrition: what can be done and at what cost?［J］. Lancet, 2013,382（9890）:452⁃477. doi: 10.1016/S0140⁃6736（13）60996⁃4.
［23］	van Nispen C, Reffett T, Long B, et al. Diagnosis and management of monkeypox: a review for the emergency clinician［J］. Ann Emerg Med, 2023,81（1）:20⁃30. doi: 10.1016/j.annemergmed.2022.07.014.
［24］	Frey SE, Wald A, Edupuganti S, et al. Comparison of lyophilized versus liquid modified vaccinia Ankara （MVA） formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia⁃naïve subjects［J］. Vaccine, 2015,33（39）:5225⁃5234. doi: 10.1016/j.vaccine.2015.06.075.
［25］	Dashraath P, Nielsen⁃Saines K, Rimoin A, et al. Monkeypox in pregnancy: virology, clinical presentation, and obstetric management［J］. Am J Obstet Gynecol, 2022,227（6）:849⁃861. doi: 10.1016/j.ajog.2022.08.017.
［26］	Centers for Disease Control and Prevention. Clinical considerations for monkeypox in children and adolescents［EB/OL］. （2022⁃07⁃26）［2025⁃07⁃20］. https://www.cdc.gov/poxvirus/ monkeypox/clinicians/pediatric.html.

[1]	Xu Zhongyi, Xing Xiaoxue, Dong Yaqi, Zhang Chengfeng, Xiang Leihong. Retrospective analysis of clinical manifestations and treatment outcomes in 254 patients with melasma in a tertiary grade-A hospital in Shanghai [J]. Chinese Journal of Dermatology, 2025, 58(9): 808-815.
[2]	Jiang Ziqi, Zhong Judan, Chen Tingqiao, Chen Jin. Pathogenesis and treatment of melasma [J]. Chinese Journal of Dermatology, 2025, 58(9): 868-872.
[3]	Zhong Jiemin, Li Wei, Zhang Shujuan, Yang Yan, Xue Rujun, Li Xinyi, Ke Yanan, Chen Xiaoyin, Chen Quan. Comparison of the efficacy and safety of nanomicroneedle- versus ultrasound-mediated delivery of tranexamic acid for the treatment of melasma: a randomized controlled study [J]. Chinese Journal of Dermatology, 2025, 58(9): 829-833.
[4]	Guliziba·Tuersun, Zhao Yanan, Wang Hongjuan, Kang Xiaojing, Qu Yuanyuan. Efficacy of autologous melanocyte transplantation combined with 308-nm light-emitting diode phototherapy at escalating doses in the treatment of refractory stable vitiligo: a clinical observation [J]. Chinese Journal of Dermatology, 2025, 58(9): 852-856.
[5]	Zhou Miaoni, Sheng Anqi, Fu Lifang, Jin Rong, Xu Wen, Wei Xiaodong, Xu Ai′e . Efficacy and safety of an antioxidant gel containing tea polyphenols combined with narrow-band ultraviolet B in the treatment of vitiligo: a single-center randomized controlled trial [J]. Chinese Journal of Dermatology, 2025, 58(9): 834-838.
[6]	Dai Yeqin, Song Xiuzu. Application of hair follicle transplantation and follicular cell suspension transplantation in the treatment of vitiligo [J]. Chinese Journal of Dermatology, 2025, 58(9): 882-885.
[7]	Jiang Qian, Hu Bin, Chen Yao, Chen Liuqing. Acquired facial hyperpigmented macules in children: a retrospective analysis of clinical and skin imaging features in 131 cases [J]. Chinese Journal of Dermatology, 2025, 58(9): 843-847.
[8]	Luo Shuaihantian, Long Hai, Lu Qianjin. Research advances in systemic lupus erythematosus in 2024 [J]. Chinese Journal of Dermatology, 2025, 58(8): 777-780.
[9]	Bai Qi, Zhu Mingfang, Wu Qingting, Ji Xiaotian, Yang Huiyi, Ma Liping, Zhou Jiaxin. Effect of sinomenine on skin lesions in 2,4-dinitrochlorobenzene-induced atopic dermatitis-like mouse models [J]. Chinese Journal of Dermatology, 2025, 58(8): 759-766.
[10]	Zhan Jinshan, Xuan Xiuyun, Cao Juanmei, Chen Fangqi, Huang Changzheng. Progress in treatment of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis [J]. Chinese Journal of Dermatology, 2025, 58(8): 785-788.
[11]	Zhang Li, Song Xiuzu. Role of vascular endothelial growth factor in androgenetic alopecia [J]. Chinese Journal of Dermatology, 2025, 58(7): 683-685.
[12]	Shao Guanghui, Li Yuqian, Chen Qitao, Zhu Qilin, Zhu Jing, Li Zhongming, Du Xufeng, Fan Weixin. Congenital triangular alopecia [J]. Chinese Journal of Dermatology, 2025, 58(7): 668-671.
[13]	Li Xiangqian, Zhang Jianzhong, Zhou Cheng. Advances in the clinical research on systemic small-molecule drugs and biologics for the treatment of alopecia areata [J]. Chinese Journal of Dermatology, 2025, 58(7): 646-649.
[14]	Lin Jinran, Leong Hiochon, Liu Qingmei, Wu Wenyu. Androgenetic alopecia and metabolic syndrome: from mechanisms to treatment strategies [J]. Chinese Journal of Dermatology, 2025, 58(7): 591-594.
[15]	Wang Qin, Lin Jinran, Liu Qingmei, Wu Wenyu, . Oral minoxidil in the treatment of alopecia areata [J]. Chinese Journal of Dermatology, 2025, 58(7): 653-656.

Focusing on the status, challenges and countermeasures of mpox susceptibility in children

PDF

Knowledge

Abstract

Cite this article

share this article

References ［26］

Related Articles 15

Metrics

Comments

Recommended 0